Lantheus Holdings (LNTH) Gross Profit (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Gross Profit came in at $230.9 million in Q1 2026, down 2.85% year-on-year from $237.7 million in Q1 2025, and down 4.13% on a QoQ basis from $240.9 million in Q4 2025.
Lantheus Holdings (LNTH) Gross Profit (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Gross Profit data on file, last reported at $230.9 million in Q1 2026.
- On a quarterly basis, Gross Profit fell 2.85% year-over-year to $230.9 million in Q1 2026; TTM through Mar 2026 was $935.2 million, a 4.98% decrease from a year earlier, with the FY2025 full-year figure at $942.0 million, down 4.69% from the prior year.
- Gross Profit for Q1 2026 stood at $230.9 million, down from $240.9 million in the prior quarter.
- Over the last five years, Gross Profit for LNTH reached as high as $255.8 million in Q2 2024 and fell as low as $77.1 million in Q1 2023.
- Historically, Gross Profit has averaged $203.1 million across 5 years, with a median of $229.9 million in 2023.
- Across the five-year window, Gross Profit surged 245.53% in 2022 and plunged 40.28% in 2023, its largest moves.
- Year by year, Gross Profit stood at $167.2 million in 2022, then soared by 37.51% to $229.9 million in 2023, then gained by 8.12% to $248.5 million in 2024, then retreated by 3.09% to $240.9 million in 2025, then decreased by 4.13% to $230.9 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $230.9 million in Q1 2026, $240.9 million in Q4 2025, and $222.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.92 Mn |
| Mar 31, 2026 | 230.92 Mn |
| Dec 31, 2025 | 240.88 Mn |
| Dec 31, 2025 | 240.88 Mn |
| Sep 30, 2025 | 222.37 Mn |
| Sep 30, 2025 | 222.37 Mn |
| Jun 30, 2025 | 241.01 Mn |
| Jun 30, 2025 | 241.01 Mn |
| Mar 31, 2025 | 237.70 Mn |
| Mar 31, 2025 | 237.70 Mn |
| Dec 31, 2024 | 248.55 Mn |
| Dec 31, 2024 | 248.55 Mn |
| Sep 30, 2024 | 242.13 Mn |
| Sep 30, 2024 | 242.13 Mn |
| Jun 30, 2024 | 255.77 Mn |
| Jun 30, 2024 | 255.77 Mn |
| Mar 31, 2024 | 241.85 Mn |
| Mar 31, 2024 | 241.85 Mn |
| Dec 31, 2023 | 229.87 Mn |
| Dec 31, 2023 | 229.87 Mn |